Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Brindle

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta|October 19, 1992
Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengthsE J Murphy, T E Bates, S R Williams, et al.
British Journal of Cancer|March 22, 2001
Combretastatin-A4 disrupts neovascular development in non-neoplastic tissueJ Griggs, R Hesketh, G A Smith, et al.
Neuroreport|March 15, 2000
Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brainR J Franklin, K L Blaschuk, M C Bearchell, et al.
British Journal of Cancer|October 7, 2010
Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarateT H Witney, M I Kettunen, D-e Hu, et al.
NMR in Biomedicine|February 20, 2018
Analysis of <sup>13</sup> C and <sup>14</sup> C labeling in pyruvate and lactate in tumor and blood of lymphoma-bearing mice injected with <sup>13</sup> C- and <sup>14</sup> C-labeled pyruvateE M Serrao, M I Kettunen, T B Rodrigues, et al.
Molecular Imaging and Biology|November 20, 2013
Towards a successful clinical implementation of fluorescence-guided surgeryT J A Snoeks, P B A A van Driel, S Keereweer, et al.
Oncogene|January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cellsS Ros, J Flöter, I Kaymak, et al.
Oncogene|July 1, 2026
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cellsS Ros, J Flöter, I Kaymak, et al.
Nature Biotechnology|January 3, 2001
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutationsL M Raamsdonk, B Teusink, D Broadhurst, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|October 19, 1992
Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengthsE J Murphy, T E Bates, S R Williams, et al.
British Journal of Cancer|March 22, 2001
Combretastatin-A4 disrupts neovascular development in non-neoplastic tissueJ Griggs, R Hesketh, G A Smith, et al.
Neuroreport|March 15, 2000
Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brainR J Franklin, K L Blaschuk, M C Bearchell, et al.
British Journal of Cancer|October 7, 2010
Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarateT H Witney, M I Kettunen, D-e Hu, et al.
NMR in Biomedicine|February 20, 2018
Analysis of <sup>13</sup> C and <sup>14</sup> C labeling in pyruvate and lactate in tumor and blood of lymphoma-bearing mice injected with <sup>13</sup> C- and <sup>14</sup> C-labeled pyruvateE M Serrao, M I Kettunen, T B Rodrigues, et al.
Molecular Imaging and Biology|November 20, 2013
Towards a successful clinical implementation of fluorescence-guided surgeryT J A Snoeks, P B A A van Driel, S Keereweer, et al.
Oncogene|January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cellsS Ros, J Flöter, I Kaymak, et al.
Oncogene|July 1, 2026
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cellsS Ros, J Flöter, I Kaymak, et al.
Nature Biotechnology|January 3, 2001
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutationsL M Raamsdonk, B Teusink, D Broadhurst, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 8